ALPA LABORATORIES LTD
ALPA · General/Diversified · NSE
₹70
Current Market Price
Fair Value (DCF)
₹59
Discount to FV
-15.3%
Updated just now
YieldIQ Score
15/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
28%
ROE
8.1%
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹146.63 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.1%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
856.7×
EBIT covers interest
Current Ratio
4.12×
Short-term liquidity
Asset Turnover
0.48×
Revenue per ₹ of assets
Revenue CAGR (3Y)
4.6%
3-year revenue growth
Revenue CAGR (5Y)
1.6%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹69.69
Bear case
Margin of Safety -291.3%
Implied upside -74.4%
Base case
Margin of Safety -22.0%
Implied upside -18.1%
Bull case
Margin of Safety +14.4%
Implied upside +16.8%
Ratio Trends
ALPA · last 10 annual periods
ROE
8.1%
ROCE
10.1%
Operating Margin
—
Debt / Equity
0.01×
PE
9.0×
EV / EBITDA
6.2×
Historical Financials
ALPA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹111 Cr | ₹92.4 Cr | ₹108 Cr | ₹112 Cr | ₹106 Cr | -1.1% |
| EBITDA | ₹21.3 Cr | ₹17.3 Cr | ₹23.0 Cr | ₹28.1 Cr | ₹19.0 Cr | -2.8% |
| EBIT | — | ₹16.2 Cr | ₹21.0 Cr | — | — | +6.8% |
| PAT | ₹14.1 Cr | ₹12.6 Cr | ₹16.8 Cr | ₹19.5 Cr | ₹15.0 Cr | +1.6% |
| EPS (diluted) | — | ₹5.90 | ₹8.01 | — | — | +7.9% |
| CFO | ₹9.9 Cr | ₹8.9 Cr | ₹3.6 Cr | ₹7.1 Cr | ₹10.0 Cr | +0.0% |
| CapEx | ₹-2.2 Cr | ₹-1.1 Cr | ₹-6.4 Cr | ₹-11.4 Cr | ₹-4.0 Cr | — |
| FCF | ₹7.7 Cr | ₹7.8 Cr | ₹-2.7 Cr | ₹-4.3 Cr | ₹6.0 Cr | -6.2% |
| Total Assets | ₹155 Cr | ₹167 Cr | ₹182 Cr | ₹223 Cr | ₹242 Cr | +11.8% |
| Total Debt | ₹5.8 Cr | ₹2.3 Cr | ₹5.2 Cr | ₹0.0 Cr | ₹2.5 Cr | -19.1% |
| Shareholders' Equity | ₹122 Cr | ₹135 Cr | ₹152 Cr | ₹171 Cr | ₹186 Cr | +11.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ALPA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
KREBSBIO KREBSBIO | — | — | Pending | 10.4% | — |
BALPHARMA BALPHARMA | — | — | Pending | 7.6% | — |
NATCAPSUQ NATCAPSUQ | — | — | Pending | 0.3% | — |
BROOKS BROOKS | — | — | Pending | 20.0% | — |
PAR PAR | — | — | Pending | 13.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ALPA in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. ALPA LABORATORIES LTD (ALPA.NS) trades at 69.69 vs a model fair value of 59.03, a gap of -15.3%. Piotroski F-score: 3/9. Moat label: None...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ALPA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ALPA →
Compare
Head-to-head with peers
Compare ALPA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ALPANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.